Picture of Oncopeptides AB logo

ONCO — Oncopeptides AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Oncopeptides Extends Market Exclusivity For Pepaxti In Europe Until 2037

Feb 15 (Reuters) - Oncopeptides AB  ONCO.ST :
    * ENSURES FIVE YEARS EXTENDED MARKET EXCLUSIVITY FOR PEPAXTI
IN
EUROPE
    * EXTENSION OF KEY PATENT IN EUROPE UNTIL 2037

Source text for Eikon:  ID:nMFN9FCnfK 
Further company coverage:  ONCO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Oncopeptides AB

See all news